Diabetes mellitus and cognitive impairment


Cite item

Full Text

Abstract

The review discusses literature data and the results of our own studies on the effect of diabetes on cognitive functions and cerebrovascular pathology, as well as possible ptogenetic mechanisms for the implementation of this effect. The results of studies on the effects of antidiabetic drugs on cognitive function are presented.

About the authors

E V Surkova

Endocrinology Research Centre

д.м.н., гл.н.с. отд-ния терапии диабета, проф. каф. диабетологии и диетологии; ORCID: 0000-0002-3973-7638 Moscow, Russia

M M Tanashyan

Research Center of Neurology

д.м.н., проф., зам. директора по научной работе, зав. 1-м неврологическим отд-нием; ORCID: 0000-00002-5883-8119 Moscow, Russia

A I Bespalov

Endocrinology Research Centre

Email: finger1ess@mail.ru
спирант отд-ния терапии диабета с референс-центром обучения; ORCID: 0000-0003-1584-5690 Moscow, Russia

A V Naminov

Research Center of Neurology

аспирант 1-го неврологического отд-ния; ORCID: 0000-0003-3394-8976 Moscow, Russia

References

  1. IDF Diabetes Atlas. 8th ed. 2017. Available from: https://www.idf.org/e-library/epidemiology-research/diabetes-atlas/134-idf-diabetes-atlas-8th-edition.html
  2. Дедов И.И., Шестакова М.В., Викулова О.К. и др. Сахарный диабет в Российской Федерации: распространенность, заболеваемость, смертность, параметры углеводного обмена и структура сахароснижающей терапии по данным федерального регистра сахарного диабета, статус 2017 г. Сахарный диабет. 2018;21(3):144-59. doi: 10.14341/DM9686
  3. Захаров В.В., Яхно Н.Н. Когнитивные расстройства в пожилом и старческом возрасте. Методическое пособие для врачей. М., 2005. 71 c.
  4. Танашян М.М., Лагода О.В., Орлов С.В. и др. Сосудистые заболевания головного мозга и метаболический синдром. Терапевтический архив. 2013;85(10):34-42.
  5. Roberts R, Knopman D.S. Classification and epidemiology of MCI. Clin Geriatr Med. 2013;29(4):753-72. doi: 10.1016/j.cger.2013.07.003
  6. Munshi M.N, Medha N. Cognitive dysfunction in older adults with diabetes: what a clinician needs to know. Diabetes Care. 2017 Apr;40(4):461-7. doi: 10.2337/dc16-1229
  7. Танашян М.М., Лагода О.В., Антонова К.В. Метаболический синдром и цереброваскулярные заболевания. Академия инсульта. Альманах №3. С. 155-64.
  8. Сосина В.Б., Захаров В.В., Строков И.А., Вахнина Н.В. Когнитивные нарушения при сахарном диабете. Неврология, нейропсихиатрия, психосоматика. 2017;9(1):90-5. doi: 10.14412/2074-2711-2017-1-90-95
  9. Пирадов М.А., Танашян M.M., Максимова М.Ю. Инсульт: современные технологии диагностики и лечения. М.: МЕДпресс - информ, 2018. 3-е изд. 121 с.
  10. Rajala U, Laakso M, Paivansalo M, et al. Blood pressure and atherosclerotic plaques in carotid, aortic and femoral arteries in elderly Finns with diabetes mellitus or impaired glucose tolerance. J Hum Hypertens. 2005;19:85-91. doi: 10.1038/sj.jhh.1001779
  11. Tuttolomondo A, Pinto A, Salemi G, Di Raimondo D, Di Sciacca R, Fernandez P, Licata G. Diabetic and non - diabetic subjects with ischemic stroke: differences, subtype distribution and outcome. Nutrit Metabol Cardiovasc Dis. 2008;18(2):152-7. doi: 10.1016/j.numecd.2007.02.003
  12. Papa G, Degano C, Iurato M.P, Licciardello C, Maiorana R, Finocchiaro C. Macrovascular complication phenotypes in type 2 diabetic patients. Cardiovasc Diabetol. 2013;12(1):20. doi: 10.1186/1475-2840-12-20
  13. Танашян М.М., ред. Сосудистые заболевания головного мозга и метаболический синдром. Руководство для врачей. М.: АСТ 345, 2017.
  14. Convit A, Wolf O.T, Tarshish C, De Leon M.J. Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly. Proc Nat Acad Sci. 2003;100(4):2019-22. doi: 10.1073/pnas.0336073100
  15. Kissela B.M, Khoury J, Kleindorfer D, Woo D, Schneider A, Alwell K, et al. Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/Northern Kentucky Stroke Study. Diabetes Care. 2005;28(2):355-9. doi: 10.2337/diacare.28.2.355
  16. Air E.L, Kissela B.M. Diabetes, the metabolic syndrome, and ischemic stroke: epidemiology and possible mechanisms. Diabetes Care. 2007;30(12):3131-40. doi: 10.2337/dc06-1537
  17. Chen R, Ovbiagele B, Feng W. Diabetes and stroke: epidemiology, pathophysiology, pharmaceuticals and outcomes. Am J Med Sci. 2016;351(4):380-6. doi: 10.1016/j.amjms.2016.01.011
  18. Hu G, Sarti C, Jousilahti P, Peltonen M, Qiao Q, Antikainen R, Tuomilehto J. The impact of history of hypertension and type 2 diabetes at baseline on the incidence of stroke and stroke mortality. Stroke. 2005;36(12):2538-43. doi: 10.1161/01.STR.0000190894.30964.75
  19. Hägg S, Thorn L.M, Putaala J, Liebkind R, Harjutsalo V, Forsblom C.M, et al, & FinnDiane Study Group. (2013). Incidence of stroke according to presence of diabetic nephropathy and severe diabetic retinopathy in patients with type 1 diabetes. Diabetes Care. 2013;36(12):4140-6. doi: 10.2337/dc13-0669
  20. Prospective D.U. Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317(7160):703. doi: 10.1136/bmj.317.7160.703
  21. Selvin E, Coresh J, Shahar E, Zhang L, Steffes M, Sharrett A.R. Glycaemia (haemoglobin A1c) and incident ischaemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Lancet Neurol. 2005;4(12):821-6. doi: 10.1016/S1474-4422(05)70227-1
  22. Ramirez A, Wolfsgruber S, Lange C, Kaduszkiewicz H, Weyerer S, Werle J, et al. Elevated HbA 1c is associated with increased risk of incident dementia in primary care patients. J Alzheimer's Dis. 2015;44(4):1203-12. doi: 10.3233/JAD-141521
  23. Xu W.L, von Strauss E, Qiu C.X, Winblad B, Fratiglioni L. Uncontrolled diabetes increases the risk of Alzheimer’s disease: a population - based cohort study. Diabetologia. 2009;52(6):1031. doi: 10.1007/s00125-009-1323-x
  24. Biessels G.J, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5(1):64-74. doi: 10.1016/S1474-4422(05)70284-2
  25. Nelson P.T, Smith C.D, Abner E.A, Schmitt F.A, Scheff S.W, Davis G.J, et al. Human cerebral neuropathology of Type 2 diabetes mellitus. Biochim Biophys Acta (BBA) - Mol Basis Dis. 2009;1792(5):454-69. doi: 10.1016/j.bbadis.2008.08.005
  26. Rawlings A.M, Sharrett A.R, Schneider A.L, Coresh J, Albert M, Couper D, et al. Diabetes in midlife and cognitive change over 20 years: a cohort study. Ann Intern Med. 2014;161(11):785-93. doi: 10.7326/M14-0737
  27. Luchsinger J.A, Tang M.X, Stern Y, Shea S, Mayeux R. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol. 2001;154(7):635-41. doi: 10.1093/aje/154.7.635
  28. Ott A, Stolk R.P, van Harskamp F, Pols H.A.P, Hofman A, Breteler M.M.B. Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology. 1999;53(9):1937-37. doi: 10.1212/WNL.53.9.1937
  29. Peila R, Rodriguez B.L, Launer L.J. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes. 2002;51(4):1256-62. doi: 10.2337/diabetes.51.4.1256
  30. Feil D.G, Rajan M, Soroka O, Tseng C.L, Miller D.R, Pogach L.M. Risk of hypoglycemia in older veterans with dementia and cognitive impairment: implications for practice and policy. J Am Geriatr Soc. 2011;59(12):2263-72. doi: 10.1111/j.1532-5415.2011.03726.x
  31. Anstey K.J, Sargent-Cox K, Eramudugolla R, Magliano D.J, Shaw J.E. Association of cognitive function with glucose tolerance and trajectories of glucose tolerance over 12 years in the AusDiab study. Alzheimer's Res Ther. 2015;7(1):48. doi: 10.1186/s13195-015-0131-4
  32. Biessels G.J, Reijmer Y.D. Brain changes underlying cognitive dysfunction in diabetes: what can we learn from MRI? Diabetes. 2014;63(7):2244-52. doi: 10.2337/db14-0348
  33. Yaffe K, Falvey C, Hamilton N, Schwartz A.V, Simonsick E.M, Satterfield S, et al. Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol. 2012;69(9):1170-5. doi: 10.1001/archneurol.2012.1117
  34. Palta P, Schneider A.L, Biessels G.J, Touradji P, Hill-Briggs F. Magnitude of cognitive dysfunction in adults with type 2 diabetes: a meta - analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains. J Intern Neuropsychol Soc. 2014;20(3):278-91. doi: 10.1017/S1355617713001483
  35. Palta P, Carlson M.C, Crum R.M, Colantuoni E, Sharrett A.R, Yasar S, et al. Diabetes and cognitive decline in older adults: the Ginkgo evaluation of memory study. J Gerontol Series A. 2017;73(1):123-30. doi: 10.1093/gerona/glx076
  36. Jacobson A.M, Musen G, Ryan C.M, Silvers N, Cleary P, Waberski B, et al. Long - term effect of diabetes and its treatment on cognitive function. New Engl J Med. 2007;356(18):1842-52. doi: 10.1056/NEJMoa066397
  37. Strachan M.W, Reynolds R.M, Frier B.M, Mitchell R.J, Price J.F. The relationship between type 2 diabetes and dementia. Brit Med Bull. 2008;88(1). doi: 10.1093/bmb/ldn042
  38. Whitmer R.A, Karter A.J, Yaffe K, Quesenberry C.P, Selby J.V. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA. 2009;301(15):1565-72. doi: 10.1001/jama.2009.460
  39. Fanelli C.G, Porcellati F, Pampanelli S, Bolli G.B. Insulin therapy and hypoglycaemia: the size of the problem. Diabet Metabol Res Rev. 2004;20(S2):S32-S42. doi: 10.1002/dmrr.514
  40. Wright R.J, Frier B.M. Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metabol Res Rev. 2008;24(5):353-63. doi: 10.1002/dmrr.865
  41. Suh S.W, Hamby A.M, Swanson R.A. Hypoglycemia, brain energetics, and hypoglycemic neuronal death. Glia. 2007;55(12):1280-6. doi: 10.1002/glia.20440
  42. Mc Crimmon R.J, Ryan C.M, Frier B.M. Diabetes and cognitive dysfunction. Lancet. 2012;379(9833):2291-9. doi: 10.1016/S0140-6736(12)60360-2
  43. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven P.D, et al. Glucose control and vascular complications in veterans with type 2 diabetes. New Engl J Med. 2009;360(2):129-39. doi: 10.1056/NEJMoa0808431
  44. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. New Engl J Med. 2008;358(24):2560-72. doi: 10.1056/NEJMoa0802987
  45. Launer L.J, Miller M.E, Williamson J.D, Lazar R.M, Gerstein H.C, Murray A.M, et al. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open - label substudy. Lancet Neurol. 2011;10(11):969-77. doi: 10.1016/S1474-4422(11)70188-0
  46. Stern Y. Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol. 2012;11(11):1006-12. doi: 10.1016/S1474-4422(12)70191-6
  47. Suzanne M. Relationships between diabetes and cognitive impairment. Endocrinol Metabol Clin. 2014;43(1):245-67. doi: 10.1016/j.ecl.2013.09.006
  48. Arab L, Sadeghi R, Walker G.D, Lue L.F, Sabbagh M. Consequences of aberrant insulin regulation in the brain: can treating diabetes be effective for Alzheimer's disease. Curr Neuropharmacol. 2011;9(4):693-705. doi: 10.2174/157015911798376334
  49. Wang X, Zheng W, Xie J.W, Wang T, Wang S.L, Teng W.P, Wang Z.Y. Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model. Mol Neurodegenerat. 2010;5(1):46. doi: 10.1186/1750-1326-5-46
  50. Musicco M, Palmer K, Salamone G, Lupo F, Perri R, Mosti S, et al. Predictors of progression of cognitive decline in Alzheimer’s disease: the role of vascular and sociodemographic factors. J Neurol. 2009;256(8):1288. doi: 10.1007/s00415-009-5116-4
  51. Sima A.A. Encephalopathies: the emerging diabetic complications. Acta Diabetol. 2010;47(4):279-93. doi: 10.1007/s00592-010-0218-0
  52. Sonnen J.A, Larson E.B, Brickell K, Crane P.K, Woltjer R, Montine T.J, Craft S. Different patterns of cerebral injury in dementia with or without diabetes. Arch Neurol. 2009;66(3):315-22. doi: 10.1001/archneurol.2008.579
  53. Cao B, Rosenblat J.D, Brietzke E, Park C, Lee Y, Musial N, et al. Comparative efficacy and acceptability of antidiabetic agents for Alzheimer's disease and mild cognitive impairment: A systematic review and network meta - analysis. Diabetes Obes Metabol. 2018;20(10):2467-71. doi: 10.1111/dom.13373
  54. Hsu C.C, Wahlqvist M.L, Lee M.S, Tsai H.N. Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin. J Alzheimer's Dis. 2011;24(3):485-93. doi: 10.3233/JAD-2011-101524
  55. Tao L, Li D, Liu H, Jiang F, Xu Y, Cao Y, et al. Neuroprotective effects of metformin on traumatic brain injury in rats associated with NF-κB and MAPK signaling pathway. Brain Res Bull. 2018;140:154-61. doi: 10.1016/j.brainresbull.2018.04.008
  56. Wang J, Gallagher D, De Vito L.M, Cancino G.I, Tsui D, He L, et al. Metformin activates an atypical PKC-CBP pathway to promote neurogenesis and enhance spatial memory formation. Cell Stem Cell. 2012;11(1):23-35. doi: 10.1016/j.stem.2012.03.016
  57. Nevado-Holgado A.J, Kim C.H, Winchester L, Gallacher J, Lovestone S. Commonly prescribed drugs associate with cognitive function: a cross - sectional study in UK Biobank. BMJ Open. 2016;6(11):e012177. doi: 10.1136/bmjopen-2016-012177
  58. Ng T.P, Feng L, Yap K.B, Lee T.S, Tan C.H, Winblad B. Long - term metformin usage and cognitive function among older adults with diabetes. J Alzheimer's Dis. 2014;41(1):61-8. doi: 10.3233/JAD-131901
  59. Rizzo M.R, Barbieri M, Boccardi V, Angellotti E, Marfella R, Paolisso G. Dipeptidyl peptidase-4 inhibitors have protective effect on cognitive impairment in aged diabetic patients with mild cognitive impairment. J Gerontol Ser A: Biomed Sci Med Sci. 2014;69(9):1122-31. doi: 10.1093/gerona/glu032
  60. Imfeld P, Bodmer M, Jick S.S, Meier C.R. Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population - based case - control study. J Am Geriatr Soc. 2012;60(5):916-21. doi: 10.1111/j.1532-5415.2012.03916.x
  61. Moore E.M, Mander A.G, Ames D, Kotowicz M.A, Carne R.P, Brodaty H, et al. Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes Care. 2013;36(10):2981-7. doi: 10.2337/dc13-0229
  62. De la Monte S.M. Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the art. Exp Opin Drug Deliv. 2013;10(12):1699-709. doi: 10.1517/17425247.2013.856877
  63. Liu M, Bian C, Zhang J, Wen F. Apolipoprotein E gene polymorphism and Alzheimer's disease in Chinese population: a meta - analysis. Sci Rep. 2014;4:4383. doi: 10.1038/srep04383
  64. Claxton A, Baker L.D, Wilkinson C.W, Trittschuh E.H, Chapman D, Watson G, Craft S. Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease. J Alzheimer's Dis. 2013;35(4):789-97. doi: 10.3233/JAD-122308
  65. Ikonomovic M.D, Klunk W.E, Abrahamson E.E, Mathis C.A, Price J.C, Tsopelas N.D, Debnath M.L. Post - mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain. 2008;31(6):1630-45. doi: 10.1093/brain/awn016
  66. Novak V, Abduljalil A.M, Novak P, Robitaille P.M. High - resolution ultrahigh - field MRI of stroke. Magnet Resonance Imag. 2005;23(4):539-48. doi: 10.1016/j.mri.2005.02.010
  67. Kodl C.T, Franc D.T, Rao J.P, Anderson F.S, Thomas W, Mueller B.A, Seaquist E.R. Diffusion tensor imaging identifies deficits in white matter microstructure in subjects with type 1 diabetes that correlate with reduced neurocognitive function. Diabetes. 2008;57(11):3083-9. doi: 10.2337/db08-0724
  68. Umegaki H. Pathophysiology of cognitive dysfunction in older people with type 2 diabetes: vascular changes or neurodegeneration? Age Ageing. 2009;39(1):8-10. doi: 10.1093/ageing/afp211
  69. Schoenle E.J, Schoenle D, Molinari L, Largo R.H. Impaired intellectual development in children with type I diabetes: association with HbA1 c, age at diagnosis and sex. Diabetologia. 2002;45(1):108-14. doi: 10.1007/s125-002-8250-6
  70. Fort P.E, Losiewicz M.K, Reiter C.E, Singh R.S, Nakamura M, Abcouwer S.F, Gardner T.W. Differential roles of hyperglycemia and hypoinsulinemia in diabetes induced retinal cell death: evidence for retinal insulin resistance. PloS One. 2011;6(10),e26498. doi: 10.1371/journal.pone.0026498
  71. Nathan D.M, Zinman B, Cleary P.A, Backlund J.Y.C, Genuth S, Miller R, Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group. Modern - day clinical course of type 1 diabetes mellitus after 30 years’ duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005). Arch Intern Med. 2009;169(14):1307. doi: 10.1001/archinternmed.2009.193
  72. Weinger K, Jacobson A.M, Musen G, Lyoo I.K, Ryan C.M, Jimerson D.C, Renshaw P.F. The effects of type 1 diabetes on cerebral white matter. Diabetologia. 2008;51(3):417-25. doi: 10.1007/s00125-007-0904-9
  73. Brands A.M, Kessels R.P, Hoogma R.P, Henselmans J.M, van der Beek Boter J.W, Kappelle L.J, Biessels G.J. Cognitive performance, psychological well - being, and brain magnetic resonance imaging in older patients with type 1 diabetes. Diabetes. 2006;55(6):1800-6. doi: 10.2337/db05-1226
  74. Luitse M.J, Biessels G.J, Rutten G.E, Kappelle L.J. Diabetes, hyperglycaemia, and acute ischaemic stroke. Lancet Neurol. 2012;11(3):261-71. doi: 10.1016/S1474-4422(12)70005-4
  75. Woerdeman J, van Duinkerken E, Wattjes M.P, Barkhof F, Snoek F.J, Moll A.C, Diamant M. Proliferative retinopathy in type 1 diabetes is associated with cerebral microbleeds, which is part of generalized microangiopathy. Diabetes Care. 2014;37(4):1165-8. doi: 10.2337/dc13-1586
  76. Sima A.A, Zhang W, Muzik O, Kreipke C.W, Rafols J.A, Hoffman W.H. Sequential abnormalities in type 1 diabetic encephalopathy and the effects of C-peptide. Rev Diabet Stud: RDS. 2009;6(3):211. doi: 10.1900/RDS.2009.6.211

Copyright (c) 2019 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies